<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">gastro-j</journal-id><journal-title-group><journal-title xml:lang="ru">Российский журнал гастроэнтерологии, гепатологии, колопроктологии</journal-title><trans-title-group xml:lang="en"><trans-title>Russian Journal of Gastroenterology, Hepatology, Coloproctology</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">1382-4376</issn><issn pub-type="epub">2658-6673</issn><publisher><publisher-name>«Gastro» LLC</publisher-name></publisher></journal-meta><article-meta><article-id custom-type="elpub" pub-id-type="custom">gastro-j-1151</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>ЛЕКЦИИ И ОБЗОРЫ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>LECTURES AND REVIEWS</subject></subj-group></article-categories><title-group><article-title>Современные подходы к лечению функциональной диспепсии</article-title><trans-title-group xml:lang="en"><trans-title>Modern approaches to functional dyspepsia treatment</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Шептулин</surname><given-names>А. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Sheptulin</surname><given-names>A. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>Шептулин Аркадий Александрович – доктор медицинских наук, профессор кафедры пропедевтики внутренних болезней</p><p>119991, Москва, ул. Погодинская, д. 1, стр. 1</p></bio><bio xml:lang="en"><p>Sheptulin Arkady A — MD, PhD, professor, Chair of internal diseases propedeutics, medical faculty</p><p>119991, Moscow, Pogodinskaya street, 1, bld 1</p></bio><email xlink:type="simple">arkalshep@gmail.com</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ГБОУ ВПО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>State educational government-financed institution of higher professional education «Sechenov First Moscow state medical university». Ministry of Healthcare of the Russian Federation</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>04</month><year>2024</year></pub-date><volume>24</volume><issue>6</issue><fpage>13</fpage><lpage>20</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Шептулин А.А., 2014</copyright-statement><copyright-year>2014</copyright-year><copyright-holder xml:lang="ru">Шептулин А.А.</copyright-holder><copyright-holder xml:lang="en">Sheptulin A.A.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://www.gastro-j.ru/jour/article/view/1151">https://www.gastro-j.ru/jour/article/view/1151</self-uri><abstract><p>Цель обзора. Отразить современные подходы к лечению больных функциональной диспепсией (ФД).Основные положения. Лечение пациентов с ФД должно быть комплексным и включать в себя общие мероприятия, применение лекарственных препаратов и психотерапевтических методов. При выборе конкретного препарата необходимо руководствоваться клиническим вариантом болезни. При болевом (язвенноподобном варианте) предпочтение отдается антисекреторным препаратам (в первую очередь, ингибиторам протонной помпы), при постпрандиальном дистресс-синдроме (дискинетическом варианте) – прокинетикам. В резистентных случаях показаны психотропные препараты и психотерапевтические методы.Заключение. В настоящее время необходимо продолжение исследований патогенеза ФД, что позволит сделать лечение более дифференцированным и улучшить его результаты.</p></abstract><trans-abstract xml:lang="en"><sec><title>The aim of review</title><p>The aim of review. To present modern approach to treatment of functional dyspepsia (FD).</p></sec><sec><title>Key points</title><p>Key points. Treatment of FD should be comprehensive and include general recommendations, application of drugs and psychotherapeutic methods. At a choice of specific drug clinical variant of disease should be taken into account. At pain-predominant (ulcer-like) variant antisecretory agents (first of all — proton pump inhibitors) are the drugs of choice, at postprandial distress syndrome (dysmotility-like variant) - prokinetics. In resistant cases psychotropic drugs and psychotherapeutic methods are indicated.</p></sec><sec><title>Conclusion</title><p>Conclusion. Investigation of FD pathogenesis should be continued that will provide more differentiated treatment approach and improve the results.</p></sec></trans-abstract><kwd-group xml:lang="ru"><kwd>функциональная диспепсия</kwd><kwd>лечение</kwd><kwd>антисекреторная терапия</kwd><kwd>прокинетики</kwd><kwd>психотропные препараты</kwd></kwd-group><kwd-group xml:lang="en"><kwd>functional dyspepsia</kwd><kwd>treatment</kwd><kwd>antisecretory therapy</kwd><kwd>prokinetics</kwd><kwd>psychotropic drugs</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией. Фарматека 2009; 13:50-4.</mixed-citation><mixed-citation xml:lang="en">Ивашкин В.Т., Шептулин А.А., Трухманов А.С. Эффективность применения ганатона (итоприда гидрохлорида) в лечении больных функциональной диспепсией. Фарматека 2009; 13:50-4.</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Ивашкин В.Т., Шептулин А.А., Киприанис В.А. Функциональная диспепсия. М., МЕДпресс, 2011.</mixed-citation><mixed-citation xml:lang="en">Ивашкин В.Т., Шептулин А.А., Киприанис В.А. Функциональная диспепсия. М., МЕДпресс, 2011.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Картавенко И.М. Морфофункциональная оценка двенадцатиперстной кишки у лиц с функциональной диспепсией: Автореф. дис. ... канд. мед. наук. М., 2008:23 с.</mixed-citation><mixed-citation xml:lang="en">Картавенко И.М. Морфофункциональная оценка двенадцатиперстной кишки у лиц с функциональной диспепсией: Автореф. дис. ... канд. мед. наук. М., 2008:23 с.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Охлобыстина О.З. Некоторые особенности патогенеза, клиники, диагностики и лечения синдрома функциональной диспепсии: Автореф. дис. ... канд. мед. наук. М., 2007:24 с.</mixed-citation><mixed-citation xml:lang="en">Охлобыстина О.З. Некоторые особенности патогенеза, клиники, диагностики и лечения синдрома функциональной диспепсии: Автореф. дис. ... канд. мед. наук. М., 2007:24 с.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Рос журн гастроэнтерол гепатол колопроктол 2012; 22(1):87-91.</mixed-citation><mixed-citation xml:lang="en">Рекомендации Российской гастроэнтерологической ассоциации по диагностике и лечению инфекции Helicobacter pylori у взрослых. Рос журн гастроэнтерол гепатол колопроктол 2012; 22(1):87-91.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Allescher H.-D., Böckenhoff A., Knapp G., et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36:934-41.</mixed-citation><mixed-citation xml:lang="en">Allescher H.-D., Böckenhoff A., Knapp G., et al. Treatment of non-ulcer dyspepsia: a meta-analysis of placebo-controlled prospective studies. Scand J Gastroenterol 2001; 36:934-41.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Altan E., Masaoka T., Farre R., Tack J. Acotiamide, a novel gastroprokinetiс for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol 2012; 6:533-44.</mixed-citation><mixed-citation xml:lang="en">Altan E., Masaoka T., Farre R., Tack J. Acotiamide, a novel gastroprokinetiс for the treatment of patients with functional dyspepsia: postprandial distress syndrome. Expert Rev Gastroenterol Hepatol 2012; 6:533-44.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Von Armin U., Peitz U., Vinson B., et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Amer J Gastroenterol 2007; 112:1268-75.</mixed-citation><mixed-citation xml:lang="en">Von Armin U., Peitz U., Vinson B., et al. STW 5, a phytopharmacon for patients with functional dyspepsia: results of a multicenter, placebo-controlled double-blind study. Amer J Gastroenterol 2007; 112:1268-75.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Bates S., Sjoden P.-O., Nyren O. Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988; 17:15565.</mixed-citation><mixed-citation xml:lang="en">Bates S., Sjoden P.-O., Nyren O. Behavioral treatment of non-ulcer dyspepsia. Scand J Behav Ther 1988; 17:15565.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Braak B., Klooker T., Lei A., et al. Effect of amitriptiyline on drinking capacity and symptoms in patients with functional dyspepsia. DDW – New Orleans, 2010. Abstract 1067.</mixed-citation><mixed-citation xml:lang="en">Braak B., Klooker T., Lei A., et al. Effect of amitriptiyline on drinking capacity and symptoms in patients with functional dyspepsia. DDW – New Orleans, 2010. Abstract 1067.</mixed-citation></citation-alternatives></ref><ref id="cit11"><label>11</label><citation-alternatives><mixed-citation xml:lang="ru">Braden B., Caspary W., Börner N., et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptiyng in patients with functional dyspepsia and gastroparesis . Neurogastroenterol. Motil. 2009; 21:632-5.</mixed-citation><mixed-citation xml:lang="en">Braden B., Caspary W., Börner N., et al. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptiyng in patients with functional dyspepsia and gastroparesis . Neurogastroenterol. Motil. 2009; 21:632-5.</mixed-citation></citation-alternatives></ref><ref id="cit12"><label>12</label><citation-alternatives><mixed-citation xml:lang="ru">Calvert E., Houghton L., Cooper P., et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002; 123:1778-85.</mixed-citation><mixed-citation xml:lang="en">Calvert E., Houghton L., Cooper P., et al. Long-term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002; 123:1778-85.</mixed-citation></citation-alternatives></ref><ref id="cit13"><label>13</label><citation-alternatives><mixed-citation xml:lang="ru">Camilleri M., Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10:187-94.</mixed-citation><mixed-citation xml:lang="en">Camilleri M., Stanghellini V. Current management strategies and emerging treatments for functional dyspepsia. Nat Rev Gastroenterol Hepatol 2013; 10:187-94.</mixed-citation></citation-alternatives></ref><ref id="cit14"><label>14</label><citation-alternatives><mixed-citation xml:lang="ru">Сonnoly M.P., Bhatt A., Simmonds R. Implementing UK National dyspepsia guidelines for returning patients to self-care: findings from an educational intervention and 12-month follow-up clinical re-audit. Gut 2009; 58 (suppl. 58). Abstract P0129.</mixed-citation><mixed-citation xml:lang="en">Сonnoly M.P., Bhatt A., Simmonds R. Implementing UK National dyspepsia guidelines for returning patients to self-care: findings from an educational intervention and 12-month follow-up clinical re-audit. Gut 2009; 58 (suppl. 58). Abstract P0129.</mixed-citation></citation-alternatives></ref><ref id="cit15"><label>15</label><citation-alternatives><mixed-citation xml:lang="ru">Futagami S., Shimpuku M., Song J.M., et al. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying. Digestion 2012; 86:114-21.</mixed-citation><mixed-citation xml:lang="en">Futagami S., Shimpuku M., Song J.M., et al. Nizatidine improves clinical symptoms and gastric emptying in patients with functional dyspepsia accompanied by impaired gastric emptying. Digestion 2012; 86:114-21.</mixed-citation></citation-alternatives></ref><ref id="cit16"><label>16</label><citation-alternatives><mixed-citation xml:lang="ru">Hamilton J., Guthrie E., Creed F., et al. A randomised controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000; 119:661-9.</mixed-citation><mixed-citation xml:lang="en">Hamilton J., Guthrie E., Creed F., et al. A randomised controlled trial of psychotherapy in patients with chronic functional dyspepsia. Gastroenterology 2000; 119:661-9.</mixed-citation></citation-alternatives></ref><ref id="cit17"><label>17</label><citation-alternatives><mixed-citation xml:lang="ru">Haug T.T., Wilhelmsen I., Sveback S., et al. Psychotherapy in functional dyspepsia. J Psychosomat Res 1994; 38:735-44.</mixed-citation><mixed-citation xml:lang="en">Haug T.T., Wilhelmsen I., Sveback S., et al. Psychotherapy in functional dyspepsia. J Psychosomat Res 1994; 38:735-44.</mixed-citation></citation-alternatives></ref><ref id="cit18"><label>18</label><citation-alternatives><mixed-citation xml:lang="ru">Holtmann G., Talley N.J., Liebregts T., et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354:832-40.</mixed-citation><mixed-citation xml:lang="en">Holtmann G., Talley N.J., Liebregts T., et al. A placebo-controlled trial of itopride in functional dyspepsia. N Engl J Med 2006; 354:832-40.</mixed-citation></citation-alternatives></ref><ref id="cit19"><label>19</label><citation-alternatives><mixed-citation xml:lang="ru">Holtmann G., Nandurkar S. Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systemic review of the literature and meta-analysis. Gastroenterology. 2007; 132 (4) Suppl. 2 (Abstract W1204)</mixed-citation><mixed-citation xml:lang="en">Holtmann G., Nandurkar S. Talley N.J., et al. Herbal medicine for the treatment of functional dyspepsia: a systemic review of the literature and meta-analysis. Gastroenterology. 2007; 132 (4) Suppl. 2 (Abstract W1204)</mixed-citation></citation-alternatives></ref><ref id="cit20"><label>20</label><citation-alternatives><mixed-citation xml:lang="ru">Huang X., Lv B., Zhang S., et al. Itopride therapy for functional dyspepsia: a meta-analysis World J Gastroenterol 2012; 18:7371-7.</mixed-citation><mixed-citation xml:lang="en">Huang X., Lv B., Zhang S., et al. Itopride therapy for functional dyspepsia: a meta-analysis World J Gastroenterol 2012; 18:7371-7.</mixed-citation></citation-alternatives></ref><ref id="cit21"><label>21</label><citation-alternatives><mixed-citation xml:lang="ru">Jackson J.L., O’Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108:65-72.</mixed-citation><mixed-citation xml:lang="en">Jackson J.L., O’Malley P.G., Tomkins G., et al. Treatment of functional gastrointestinal disorders with antidepressant medications: a meta-analysis. Am J Med 2000; 108:65-72.</mixed-citation></citation-alternatives></ref><ref id="cit22"><label>22</label><citation-alternatives><mixed-citation xml:lang="ru">Kamiya T., Shikano M., Mizushima T., et al. Comparison of rabeprazole and itopride in the treatment of functional dyspepsia sub-analysis: Nagoya multicentre randomised comparative trial. DDW – New Orleans, 2010. Abstract T1095.</mixed-citation><mixed-citation xml:lang="en">Kamiya T., Shikano M., Mizushima T., et al. Comparison of rabeprazole and itopride in the treatment of functional dyspepsia sub-analysis: Nagoya multicentre randomised comparative trial. DDW – New Orleans, 2010. Abstract T1095.</mixed-citation></citation-alternatives></ref><ref id="cit23"><label>23</label><citation-alternatives><mixed-citation xml:lang="ru">Karamanolis G., Tack J. Promotility medications – now and in the future. Dig Dis 2006; 24:297-307.</mixed-citation><mixed-citation xml:lang="en">Karamanolis G., Tack J. Promotility medications – now and in the future. Dig Dis 2006; 24:297-307.</mixed-citation></citation-alternatives></ref><ref id="cit24"><label>24</label><citation-alternatives><mixed-citation xml:lang="ru">Kinoshita Y., Chiba T. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroupe analysis from FUTURE study. J Gastroenterol 2012; 47:377-86.</mixed-citation><mixed-citation xml:lang="en">Kinoshita Y., Chiba T. Therapeutic effects of famotidine on chronic symptomatic gastritis: subgroupe analysis from FUTURE study. J Gastroenterol 2012; 47:377-86.</mixed-citation></citation-alternatives></ref><ref id="cit25"><label>25</label><citation-alternatives><mixed-citation xml:lang="ru">Lan L., Yu J., Chen Y.L. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol 2011; 17:3242-7.</mixed-citation><mixed-citation xml:lang="en">Lan L., Yu J., Chen Y.L. Symptom-based tendencies of Helicobacter pylori eradication in patients with functional dyspepsia. World J Gastroenterol 2011; 17:3242-7.</mixed-citation></citation-alternatives></ref><ref id="cit26"><label>26</label><citation-alternatives><mixed-citation xml:lang="ru">Madisch A., Melderis H., Mayr G. et al. Ein Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie. Z.Gastroenterologie 2001; 39:1-8</mixed-citation><mixed-citation xml:lang="en">Madisch A., Melderis H., Mayr G. et al. Ein Phytotherapeutikum und seine modifizierte Rezeptur bei funktioneller Dyspepsie. Z.Gastroenterologie 2001; 39:1-8</mixed-citation></citation-alternatives></ref><ref id="cit27"><label>27</label><citation-alternatives><mixed-citation xml:lang="ru">Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:2719.</mixed-citation><mixed-citation xml:lang="en">Madisch A., Holtmann G., Plein K., Hotz J. Treatment of irritable bowel syndrome with herbal preparations: results of a double-blind, randomized, placebo-controlled, multi-centre trial. Aliment Pharmacol Ther 2004; 19:2719.</mixed-citation></citation-alternatives></ref><ref id="cit28"><label>28</label><citation-alternatives><mixed-citation xml:lang="ru">Malfertheiner P., Megraud F., O’Morain C., et al. Management of Helicobacter pylori infection – the Maastricht IV Florens Consensus Report. Gut 2012; 61:646-64.</mixed-citation><mixed-citation xml:lang="en">Malfertheiner P., Megraud F., O’Morain C., et al. Management of Helicobacter pylori infection – the Maastricht IV Florens Consensus Report. Gut 2012; 61:646-64.</mixed-citation></citation-alternatives></ref><ref id="cit29"><label>29</label><citation-alternatives><mixed-citation xml:lang="ru">Matsueda K. Hongo M., Tack J., et al. A placebocontrolled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61:821-8.</mixed-citation><mixed-citation xml:lang="en">Matsueda K. Hongo M., Tack J., et al. A placebocontrolled trial of acotiamide for meal-related symptoms of functional dyspepsia. Gut 2012; 61:821-8.</mixed-citation></citation-alternatives></ref><ref id="cit30"><label>30</label><citation-alternatives><mixed-citation xml:lang="ru">Mazzoleni L.E., Sander G.B., Francesconi C.F., et al. Helicobacter pylori eradication in functional dyspepsia: HERDES trial. Arch Intern Med 2011; 28:1929-36.</mixed-citation><mixed-citation xml:lang="en">Mazzoleni L.E., Sander G.B., Francesconi C.F., et al. Helicobacter pylori eradication in functional dyspepsia: HERDES trial. Arch Intern Med 2011; 28:1929-36.</mixed-citation></citation-alternatives></ref><ref id="cit31"><label>31</label><citation-alternatives><mixed-citation xml:lang="ru">McQuaid K.R. Dyspepsia. In: Sleisenger and Fordtran’s gastrointestinal and liver disease / Eds. M. Feldman et al. 7 t h ed. Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002:102-18.</mixed-citation><mixed-citation xml:lang="en">McQuaid K.R. Dyspepsia. In: Sleisenger and Fordtran’s gastrointestinal and liver disease / Eds. M. Feldman et al. 7 t h ed. Philadelphia–London–Toronto–Montreal– Sydney–Tokyo, 2002:102-18.</mixed-citation></citation-alternatives></ref><ref id="cit32"><label>32</label><citation-alternatives><mixed-citation xml:lang="ru">Miwa H., Nagahara A. Symptomatic response pattern to PPI in FD/NERD patients is not so simple – when should we change the treatment option? DDW – New Orleans, 2010. Abstract T1016.</mixed-citation><mixed-citation xml:lang="en">Miwa H., Nagahara A. Symptomatic response pattern to PPI in FD/NERD patients is not so simple – when should we change the treatment option? DDW – New Orleans, 2010. Abstract T1016.</mixed-citation></citation-alternatives></ref><ref id="cit33"><label>33</label><citation-alternatives><mixed-citation xml:lang="ru">Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2012; 28:602-7.</mixed-citation><mixed-citation xml:lang="en">Moayyedi P. Dyspepsia. Curr Opin Gastroenterol 2012; 28:602-7.</mixed-citation></citation-alternatives></ref><ref id="cit34"><label>34</label><citation-alternatives><mixed-citation xml:lang="ru">Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127:1329-37.</mixed-citation><mixed-citation xml:lang="en">Moayyedi P., Delaney B.C., Vakil N. The efficacy of proton pump inhibitors in non-ulcer dyspepsia: a systematic review and economic analysis. Gastroenterology 2004; 127:1329-37.</mixed-citation></citation-alternatives></ref><ref id="cit35"><label>35</label><citation-alternatives><mixed-citation xml:lang="ru">Moayyedi P., Soo S., Deeks J., et al. Systemic review: Antacids, H 2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003; 17:1215-27.</mixed-citation><mixed-citation xml:lang="en">Moayyedi P., Soo S., Deeks J., et al. Systemic review: Antacids, H 2-receptor antagonists, prokinetics, bismuth and sucralfate therapy for non-ulcer dyspepsia. Aliment Pharmacol Ther 2003; 17:1215-27.</mixed-citation></citation-alternatives></ref><ref id="cit36"><label>36</label><citation-alternatives><mixed-citation xml:lang="ru">Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia. World J Gastroenterol 2006; 12:2694-700.</mixed-citation><mixed-citation xml:lang="en">Mönkemüller K., Malfertheiner P. Drug treatment of functional dyspepsia. World J Gastroenterol 2006; 12:2694-700.</mixed-citation></citation-alternatives></ref><ref id="cit37"><label>37</label><citation-alternatives><mixed-citation xml:lang="ru">Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast) – a safe and effective standart in the treatment of functional gastrointestinal disorders. Wiem Med Wochenschr 2012. DOI 10. 1007/ s10354-012-0160-x.</mixed-citation><mixed-citation xml:lang="en">Ottilinger B., Storr M., Malfertheiner P., Allescher H.-D. STW 5 (Iberogast) – a safe and effective standart in the treatment of functional gastrointestinal disorders. Wiem Med Wochenschr 2012. DOI 10. 1007/ s10354-012-0160-x.</mixed-citation></citation-alternatives></ref><ref id="cit38"><label>38</label><citation-alternatives><mixed-citation xml:lang="ru">Patel A., Kushnir V., Sayuk G.S. The impact of gastric emptying studies in the management of functional dyspepsia. DDW – New Orleans, 2010. Abstract W1399.</mixed-citation><mixed-citation xml:lang="en">Patel A., Kushnir V., Sayuk G.S. The impact of gastric emptying studies in the management of functional dyspepsia. DDW – New Orleans, 2010. Abstract W1399.</mixed-citation></citation-alternatives></ref><ref id="cit39"><label>39</label><citation-alternatives><mixed-citation xml:lang="ru">Rösch W., Vinson B., Sassin I. A randomized clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z.Gastroenterol. 2002; 40:401-8.</mixed-citation><mixed-citation xml:lang="en">Rösch W., Vinson B., Sassin I. A randomized clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia. Z.Gastroenterol. 2002; 40:401-8.</mixed-citation></citation-alternatives></ref><ref id="cit40"><label>40</label><citation-alternatives><mixed-citation xml:lang="ru">Sakaguchi M., Takao M., Ohyama Y. Comparison on PPIs and H 2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 2012; 18:1517-24.</mixed-citation><mixed-citation xml:lang="en">Sakaguchi M., Takao M., Ohyama Y. Comparison on PPIs and H 2-receptor antagonists plus prokinetics for dysmotility-like dyspepsia. World J Gastroenterol 2012; 18:1517-24.</mixed-citation></citation-alternatives></ref><ref id="cit41"><label>41</label><citation-alternatives><mixed-citation xml:lang="ru">Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for non-ulcer dyspepsia. Am J Gastroenterol 2004; 99:1817-22.</mixed-citation><mixed-citation xml:lang="en">Soo Sh., Forman D., Delaney C., Moayyedi P. A systemic review of psychological therapies for non-ulcer dyspepsia. Am J Gastroenterol 2004; 99:1817-22.</mixed-citation></citation-alternatives></ref><ref id="cit42"><label>42</label><citation-alternatives><mixed-citation xml:lang="ru">Tack J, Janssen P., Masaoka T., et al. Efficacy of buspirone, a fundus-relaxing dtug in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10:1239-45.</mixed-citation><mixed-citation xml:lang="en">Tack J, Janssen P., Masaoka T., et al. Efficacy of buspirone, a fundus-relaxing dtug in patients with functional dyspepsia. Clin Gastroenterol Hepatol 2012; 10:1239-45.</mixed-citation></citation-alternatives></ref><ref id="cit43"><label>43</label><citation-alternatives><mixed-citation xml:lang="ru">Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:146679.</mixed-citation><mixed-citation xml:lang="en">Tack J., Talley N.J., Camilleri M., et al. Functional gastroduodenal disorders. Gastroenterology 2006; 130:146679.</mixed-citation></citation-alternatives></ref><ref id="cit44"><label>44</label><citation-alternatives><mixed-citation xml:lang="ru">Talley N.J., Herrick L., Locke G.R. Antidepressants in functional dyspepsia. Exp Rev Gastroenterol Hepatol 2010; 4:5-8.</mixed-citation><mixed-citation xml:lang="en">Talley N.J., Herrick L., Locke G.R. Antidepressants in functional dyspepsia. Exp Rev Gastroenterol Hepatol 2010; 4:5-8.</mixed-citation></citation-alternatives></ref><ref id="cit45"><label>45</label><citation-alternatives><mixed-citation xml:lang="ru">Tan V.P., Cheung T.K., Wong W.M., et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012; 18:127-33.</mixed-citation><mixed-citation xml:lang="en">Tan V.P., Cheung T.K., Wong W.M., et al. Treatment of functional dyspepsia with sertraline: a double-blind randomized placebo-controlled pilot study. World J Gastroenterol 2012; 18:127-33.</mixed-citation></citation-alternatives></ref><ref id="cit46"><label>46</label><citation-alternatives><mixed-citation xml:lang="ru">Tominaga K., Suzuki H., Umegaki E., et al. Rabeprazole improves the symptoms of functional dyspepsia – a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study. DDW – New Orleans, 2010. Abstract 383.</mixed-citation><mixed-citation xml:lang="en">Tominaga K., Suzuki H., Umegaki E., et al. Rabeprazole improves the symptoms of functional dyspepsia – a double-blind randomized placebo-controlled multi-center trial in Japan: The CAESAR study. DDW – New Orleans, 2010. Abstract 383.</mixed-citation></citation-alternatives></ref><ref id="cit47"><label>47</label><citation-alternatives><mixed-citation xml:lang="ru">Van Kerkhoven L.F., Laheij R.J., Aparico N. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008; 6:746-52.</mixed-citation><mixed-citation xml:lang="en">Van Kerkhoven L.F., Laheij R.J., Aparico N. Effect of the antidepressant venlafaxine in functional dyspepsia: a randomized, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2008; 6:746-52.</mixed-citation></citation-alternatives></ref><ref id="cit48"><label>48</label><citation-alternatives><mixed-citation xml:lang="ru">Veldhuyzen van Zanten S.J., Chiba N., Armstrong D., et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADETHN study. Am J Gastroenterol 2005; 2005:1477-89.</mixed-citation><mixed-citation xml:lang="en">Veldhuyzen van Zanten S.J., Chiba N., Armstrong D., et al. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in Helicobacter pylori negative, primary care patients with dyspepsia: the CADETHN study. Am J Gastroenterol 2005; 2005:1477-89.</mixed-citation></citation-alternatives></ref><ref id="cit49"><label>49</label><citation-alternatives><mixed-citation xml:lang="ru">Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., Talley N.J. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastoenterol 2001; 96:689-96.</mixed-citation><mixed-citation xml:lang="en">Veldhuyzen van Zanten S.J., Jones M.J., Verlinden M., Talley N.J. Efficacy of cisapride and domperidone in functional dyspepsia: a meta-analysis. Am J Gastoenterol 2001; 96:689-96.</mixed-citation></citation-alternatives></ref><ref id="cit50"><label>50</label><citation-alternatives><mixed-citation xml:lang="ru">Wu C., Chou L., Chen H., et al. Effect of fluoxetine on symptoms, sleep and visceral perception in patients with functional dyspepsia. Hepatogastroenterology 2003; 50:278-83.</mixed-citation><mixed-citation xml:lang="en">Wu C., Chou L., Chen H., et al. Effect of fluoxetine on symptoms, sleep and visceral perception in patients with functional dyspepsia. Hepatogastroenterology 2003; 50:278-83.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
